Nuchev Doubles Revenue to $22.9m as Oli6® Expands Across Asia

Strong Revenue Growth and Market Expansion

Nuchev Limited has delivered a robust financial performance for the full year ending June 30, 2025, with group revenue doubling to $22.9 million. This growth was primarily driven by the continued momentum of its flagship brand Oli6® Nutritionals, which saw a 31% increase in sales across Australia and New Zealand (ANZ), China’s cross-border e-commerce (CBEC) channels, and a new market entry in Vietnam. The company’s strategic acquisition and integration of bWellness’s Practitioner channel also contributed significantly, adding $8.5 million in incremental sales.

Improved Profitability Metrics Amid Integration

While Nuchev remains in a loss position, the adjusted EBITDA loss narrowed by 49% to $3.0 million, reflecting improved operational efficiencies and margin expansion. The company highlighted a net contribution margin increase to $6.0 million, up $5.5 million from the prior year, supported by a favorable product mix, enhanced marketing return on investment, and cost synergies from the bWellness integration. Cost control measures, particularly in warehousing, distribution, and general administration, have further strengthened the financial position.

Strategic Priorities Focused on Growth and Profitability

Nuchev’s refreshed three-year strategic plan emphasizes global expansion, innovation-led product development, unified brand leadership under the “One Nuchev” approach, and accelerated sales and marketing efforts powered by digital enablement. The company aims to scale Oli6® into a full life-stage brand and broaden its health ecosystem by entering adjacent categories and expanding its footprint in Southeast Asia. Notably, the exclusive sales agency agreement with Brauer and H&S brands signals a potential shift to a distribution agreement later in 2025, which could further enhance market reach.

Solid Balance Sheet and Cash Flow Management

At June 30, 2025, Nuchev held $3.6 million in cash with no external debt, underscoring a conservative financial stance amid growth investments. The company reported improved operating cash outflows, reduced by 27% year-on-year, driven by higher-margin sales in the Practitioner channel, better marketing efficiency, and disciplined working capital management. Inventory levels remain aligned with forecast sales growth, reflecting effective supply chain optimization.

Looking Ahead

With a solid foundation established through strategic acquisitions, market expansion, and operational improvements, Nuchev is positioning itself for sustainable growth and eventual profitability. The company’s focus on innovation and brand unification could unlock further value, while upcoming developments in distribution partnerships and new product launches will be critical to watch.